Kundu S - Search Results

1

Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression.

Larsson C, Cordeddu L, Siggens L, Pandzic T, Kundu S, He L, Ali MA, Pristovšek N, Hartman K, Ekwall K, Sjöblom T. Larsson C, et al. Among authors: kundu s. Clin Epigenetics. 2020 May 29;12(1):74. doi: 10.1186/s13148-020-00863-z. Clin Epigenetics. 2020. PMID: 32471474 Free PMC article.

2

Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia.

Pandzic T, Larsson J, He L, Kundu S, Ban K, Akhtar-Ali M, Hellström AR, Schuh A, Clifford R, Blakemore SJ, Strefford JC, Baumann T, Lopez-Guillermo A, Campo E, Ljungström V, Mansouri L, Rosenquist R, Sjöblom T, Hellström M. Pandzic T, et al. Among authors: kundu s. Clin Cancer Res. 2016 Dec 15;22(24):6217-6227. doi: 10.1158/1078-0432.CCR-15-2903. Epub 2016 Mar 8. Clin Cancer Res. 2016. PMID: 26957556

3

Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer.

Mathot L, Kundu S, Ljungström V, Svedlund J, Moens L, Adlerteg T, Falk-Sörqvist E, Rendo V, Bellomo C, Mayrhofer M, Cortina C, Sundström M, Micke P, Botling J, Isaksson A, Moustakas A, Batlle E, Birgisson H, Glimelius B, Nilsson M, Sjöblom T. Mathot L, et al. Among authors: kundu s. Cancer Res. 2017 Apr 1;77(7):1730-1740. doi: 10.1158/0008-5472.CAN-16-1921. Epub 2017 Jan 20. Cancer Res. 2017. PMID: 28108514

4

Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth.

Pandzic T, Rendo V, Lim J, Larsson C, Larsson J, Stoimenov I, Kundu S, Ali MA, Hellström M, He L, Lindroth AM, Sjöblom T. Pandzic T, et al. Among authors: kundu s. Oncotarget. 2017 Oct 9;8(58):98646-98659. doi: 10.18632/oncotarget.21713. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228717 Free PMC article.

5

Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells.

Kundu S, Ali MA, Handin N, Padhan N, Larsson J, Karoutsou M, Ban K, Wiśniewski JR, Artursson P, He L, Hellström M, Sjöblom T. Kundu S, et al. Genome Med. 2018 Jan 4;10(1):2. doi: 10.1186/s13073-017-0511-4. Genome Med. 2018. PMID: 29301589 Free PMC article.

6

Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer.

Rendo V, Kundu S, Rameika N, Ljungström V, Svensson R, Palin K, Aaltonen L, Stoimenov I, Sjöblom T. Rendo V, et al. Among authors: kundu s. Sci Rep. 2020 Dec 31;10(1):22436. doi: 10.1038/s41598-020-80288-z. Sci Rep. 2020. PMID: 33384440 Free PMC article.

7

Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis.

Kundu S, Ali MA, Handin N, Conway LP, Rendo V, Artursson P, He L, Globisch D, Sjöblom T. Kundu S, et al. J Exp Clin Cancer Res. 2021 Jul 7;40(1):225. doi: 10.1186/s13046-021-02025-2. J Exp Clin Cancer Res. 2021. PMID: 34233735 Free PMC article.

8

Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions.

Jakobsson AW, Kundu S, Guo J, Chowdhury A, Zhao M, Lindell E, Bergsten P, Swartling FJ, Sjöblom T, Zhang X. Jakobsson AW, et al. Among authors: kundu s. Cancers (Basel). 2022 Jun 30;14(13):3225. doi: 10.3390/cancers14133225. Cancers (Basel). 2022. PMID: 35805002 Free PMC article.

9

Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity.

Zhang X, Akcan E, Correia M, Rameika N, Kundu S, Stoimenov I, Rendo V, Eriksson AU, Haraldsson M, Globisch D, Sjöblom T. Zhang X, et al. Among authors: kundu s. Biochem Pharmacol. 2022 Sep;203:115184. doi: 10.1016/j.bcp.2022.115184. Epub 2022 Jul 22. Biochem Pharmacol. 2022. PMID: 35872325 Free article.

10

Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells.

Kundu S, Nunes L, Adler J, Mathot L, Stoimenov I, Sjöblom T. Kundu S, et al. Cell Commun Signal. 2023 Dec 15;21(1):354. doi: 10.1186/s12964-023-01378-9. Cell Commun Signal. 2023. PMID: 38102712 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,358 results

Search Page